Stock quote - Summary

Fusion Antibodies Ord 4p
FAB: 66.50 0.00 ( 0.00 %) delayed: 16:57PM
Bid price 65.00 High price 0.00
Ask price 68.00 Low price 0.00
Open price 0.00 Spread 4.41%
Prev close 66.50 Volume 0

Fusion Antibodies Ord 4p - Share price charts

Intraday
Historic - 6 months

Advanced Fusion Antibodies Ord 4p charts >

Fusion Antibodies Ord 4p - Share price information
Name Fusion Antibodies Ord 4p Epic FAB
Activities Fusion Antibodies plc is a Belfast based contract research organisation (CRO) providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation. These services include antigen expression, antibody production, purification and sequencing, antibody humanisation using Fusion's proprietary CDRxTM platform and the production of antibody generating stable cell lines to provide material for use in clinical trials. Since 2012, the Company has successfully sequenced over 250 antibodies and successfully completed over 100 humanisation projects for its international, blue-chip client base, which includes eight of the top 10 global pharmaceutical companies by revenue. The Company was established in 2001 as a spin out from Queen's University Belfast. It was initially a drug development business but revised its operations to focus on CRO work in 2011. The Company has a highly experienced management team with a combined 47 years' experience in the biopharma industry. ISIN GB00BDQZGK16
Latest Share Price (p) 66.50 Net Gearing (%) -17.56
Market Capitalisation (pm) 14.69 Gross Gearing (%) 14.23
Shares in issue (m) 22.09 Debt Ratio 1.69
P/E Ratio -11.67 Debt-to-Equity Ratio 0.10
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.17
Dividend Yield (%) 0.00 Price to book value 2.75
Dividend Cover 0.00 ROCE (%) -27.57
Earning per share (p) -5.70 EPS Growth (%) -32.56
52-week high / low (p) 85.00 / 25.00 DPS Growth (%) n/a
Fusion Antibodies Ord 4p - Director deals
Date Director Type Volume / Price Trade value
26 Sep 2019 Dr Alan Mawson Buy 15,000 @ 65.00p £9,750.00
03 Jul 2019 Sonya Ferguson Buy 30,000 @ 69.50p £20,850.00
03 Jul 2019 Dr Alan Mawson Buy 10,000 @ 59.00p £5,900.00
03 Jul 2019 Paul Kerr Buy 6,920 @ 72.90p £5,044.40
29 Apr 2019 Paul Kerr Buy 1,290 @ 77.00p £993.30

More Fusion Antibodies Ord 4p director deals >

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.